Active Ingredient History
Ibudilast is an anti-inflammatory drug used mainly in Japan, which acts as a phosphodiesterase inhibitor, inhibiting the PDE4 subtype to the greatest extent, but also showing significant inhibition of other PDE subtypes. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Alcoholism (Phase 2)
Amyotrophic Lateral Sclerosis (Phase 2/Phase 3)
Diabetic Neuropathies (Phase 1/Phase 2)
Glioblastoma (Phase 1/Phase 2)
Headache Disorders, Secondary (Phase 1/Phase 2)
Healthy Volunteers (Phase 1)
HIV Infections (Phase 2)
Methamphetamine (Phase 2)
Migraine Disorders (Phase 1)
Multiple Sclerosis, Chronic Progressive (Phase 2)
Opioid-Related Disorders (Phase 2)
Pneumonia, Viral (Phase 2)
Spinal Cord Diseases (Phase 3)
Substance-Related Disorders (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue